Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £0 | £1 | £1 | £2 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1 | £1 | £2 | £3 |
| Revenue | £1 | £1 | £1 | £1 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | £1 | £1 | £1 | £1 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | £0 | £0 | £0 |